Navigation Links
DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
Date:10/2/2008

- Dr. Robert Weiss, Director of Maryland Laser, Skin and Vein Institute, Introduces DOT Therapy to his practice -

BALTIMORE, Oct. 2 /PRNewswire/ -- Robert Weiss, M.D., board certified dermatologist, is among the first physicians in the U.S. to offer his patients DOT Therapy (Dermal Optical Thermolysis), the latest, state-of-the-art procedure in laser skin resurfacing. Dr. Weiss is an internationally renowned dermatologist, who is in private practice in Hunt Valley, Md. and is also Director, Maryland Laser, Skin and Vein Institute.

According to Dr. Weiss, "DOT Therapy is a highly effective tool for reversing signs of aging of the skin. The key is in the way the engineers have designed the laser application for the skin. And, skin numbing cream is all that is needed."

DOT Therapy has taken laser skin rejuvenation to a whole new level.

-- This new procedure precisely delivers CO2 laser energy targeting the

face, neck, decolletage, hand and arms, opening up whole new areas for

laser rejuvenation.

-- DOT Therapy effectively improves sun damage, brown spots, wrinkles, fine

lines, and acne scarring with little downtime or discomfort -- usually

in minutes.

-- Patients are pleased with the face and body skin tightening and

improvement of crepe skin.

-- The SmartXide DOT laser system has the unique capability to deliver a

customized pattern of tiny, micro-sized dots, rather than treating the

entire skin surface, so healing is fast.

DOT Therapy has been introduced through an alliance between Eclipsemed, Ltd., one of the country's leading aesthetic laser distributors, and DEKA, one of the world's largest laser manufacturers. The SmartXide DOT system is an advanced CO2 (carbon dioxide) laser. The CO2 laser is the most common type of laser used for skin resurfacing: thoroughly proven and tested. CO2 lasers of the past covered the entire surface of the skin, resulting in a significant amount of downtime to heal, discomfort for the patient and prolonged redness of the skin. In addition, the old CO2 lasers could not treat non-facial areas like the neck and decolletage easily because skin in these areas did not heal as well as the face. DOT Therapy has received clearance from the Food & Drug Administration.

For more information, please visit http://www.dottherapy.com or http://www.eclipsemed.com.

Press Contact: Wendy Maurice, wendy@trentandcompany.com

Marketing Contact: Michelle Peters, mpeters@eclipsemed.com


'/>"/>
SOURCE Eclipsemed, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
2. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
3. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
4. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
5. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
6. Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
7. Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
8. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
9. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
10. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
11. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... 5, 2017  Just 18 months after its February ... to announce the appointment of three new senior people ... Dominic Jones-Phillips and James Wright ... Tammy Wynne joins ... access writers. She has over ten years, experience in ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... ... to Moorwick”: the adventures of a young Scottish girl yearning to see the world. ... mother of five who used her time waiting for children to finish their extracurricular activities ... It was a way to give some meaning to the hours I waited for ...
(Date:9/20/2017)... ... 2017 , ... “Monique”: is the story of Monique, whose mother’s deteriorating ... published author, Colleen Crispi, has owned four beauty salons and written a book regarding ... estate and cooking. , “The doctor’s office was only three blocks away, and ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, a leading strategy, ... Flannery, to its strategic advisory and client development team. , In her ... clients across different industries to develop and implement market-justified strategies, modernize and transform ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter ... the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID ...
(Date:9/19/2017)... ... September 19, 2017 , ... CTNext , ... Innovation Awards (EIA), held this past Thursday night at The Space in Hamden. ... presented their innovative project ideas to a panel of judges for an opportunity ...
Breaking Medicine News(10 mins):